Tag: Prescription Drugs
Hydroxychloroquine-Remdesivir Combo Dangerous for COVID-19 Patients
FDA says chloroquine or hydroxychloroquine could reduce the antiviral effectiveness of remdesivir
Four Months of Rifampin Costs Less Than Nine Months Isoniazid
Health system use and costs higher for nine months of isoniazid in adults and children in all settings
FDA Pulls Emergency Approval of Hydroxychloroquine for COVID-19
Agency now says the drugs should not be used outside of clinical trials
Acalabrutinib Promising for Treatment of Severe COVID-19
Selective bruton tyrosine kinase inhibitor treatment may improve oxygenation, reduce inflammation
Study Will Assess Drugs Used to Treat Young COVID-19 Patients
Findings will be used to refine drug dosing and improve safety for young patients with COVID-19
Blood Pressure Treatment Even Effective in Frail Older Adults
Survival benefit seen in all adherent older people, but healthier older people survived longer
Antiepileptic Drugs May Up Death Risk in Patients With Alzheimer Disease
Mortality risk highest during the first three months of treatment with antiepileptic drugs
COVID-19 Mortality Higher for Those Not Taking Meds for Their HTN
Mortality similar with renin-angiotensin-aldosterone system inhibitor, non-RAAS inhibitor for HTN
Pneumonia Risk Down With Nitrogen-Containing Bisphosphonates
Reductions in risk for pneumonia and pneumonia mortality seen among patients with hip fracture
Rituximab + Chemo Ups Survival in Pediatric B-Cell Non-Hodgkin Lymphoma
Event-free survival significantly longer for children, teens with high-grade, high-risk disease
